NCT07523958 Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery
| NCT ID | NCT07523958 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Medipol University Hospital |
| Condition | Pressure Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-01-12 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2026-01-12 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of topical paraffin oil application in preventing tourniquet-related skin lesions in patients undergoing upper extremity surgery. Pneumatic tourniquets are commonly used to provide a bloodless surgical field; however, they may cause skin complications such as erythema, edema, abrasions, blisters, and burns. In this study, adult patients undergoing elective upper extremity surgery will be randomly assigned to either an intervention group receiving topical paraffin oil application in addition to routine protective dressing or a control group receiving routine care only. Skin integrity will be assessed immediately after tourniquet removal and at 30 and 60 minutes postoperatively using standardized skin assessment criteria. The findings of this study are expected to contribute to the development of effective, simple, and cost-efficient strategies to prevent tourniquet-related skin complications and improve patient safety and postoperative comfort.
Eligibility Criteria
IInclusion Criteria: * Age ≥18 years * Patients scheduled for elective upper extremity surgery requiring pneumatic tourniquet application * ASA physical status I-III * Body mass index (BMI) \<30 kg/m² * Ability to provide informed consent * Willingness to participate in the study Exclusion Criteria: * Age \<18 years * Known dermatological disease or existing skin lesion at the tourniquet application site * Allergy or sensitivity to paraffin oil or related substances * Severe systemic disease (ASA IV or higher) * Obesity (BMI ≥30 kg/m²) * Emergency surgery * Patients transferred to intensive care postoperatively * Development of major postoperative complications (e.g., hematoma, seroma, nerve injury, significant bleeding) * Inability to communicate or comply with study procedures * Withdrawal from the study at any time
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07523958 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pressure Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07523958 currently recruiting?
Yes, NCT07523958 is actively recruiting participants. Contact the research team at muzeyyenataseven@hotmail.com for enrollment information.
Where is the NCT07523958 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07523958 clinical trial?
NCT07523958 is sponsored by Istanbul Medipol University Hospital. The trial plans to enroll 90 participants.